臺北醫學大學新藥開發研究中心

Medicine & Life Sciences

1. Histone Deacetylase Inhibitors 100%
2. Neoplasms 74%
3. Histone Deacetylases 55%
4. Apoptosis 50%
5. Mucocutaneous Lymph Node Syndrome 48%
6. Inhibitory Concentration 50 45%
7. Growth 41%
8. Taiwan 40%
9. Glioblastoma 39%
10. Antineoplastic Agents 37%
11. Colorectal Neoplasms 36%
12. In Vitro Techniques 36%
13. Proteins 35%
14. Tubulin 35%
15. Tubulin Modulators 32%
16. Therapeutics 30%
17. Pharmaceutical Preparations 29%
18. Genes 29%
19. Microtubules 28%
20. Phosphorylation 28%
21. denbinobin 27%
22. Non-Small Cell Lung Carcinoma 27%
23. osthol 27%
24. Down-Regulation 27%
25. Autophagy 27%
26. Population 26%
27. Heterografts 26%
28. Cell Line 26%
29. Breast Neoplasms 25%
30. Temozolomide 24%
31. Lung Neoplasms 24%
32. Cell Movement 24%
33. hispidulin 23%
34. 3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide 22%
35. Single Nucleotide Polymorphism 21%
36. Cell Death 21%
37. Gene Expression 21%
38. Histone Deacetylase 6 21%
39. Acetylation 20%
40. indoline 19%
41. Reactive Oxygen Species 18%
42. Hydroxamic Acids 18%
43. Vorinostat 18%
44. Intravenous Immunoglobulins 18%
45. Stromal Interaction Molecule 1 17%
46. Aryl Hydrocarbon Receptors 17%
47. Triple Negative Breast Neoplasms 17%
48. Cell Proliferation 17%
49. Glioma 17%
50. Nanoparticles 17%
51. Neoplasm Metastasis 16%
52. Hypoxia-Inducible Factor 1 16%
53. Cyclooxygenase 2 16%
54. Up-Regulation 15%
55. Ankylosing Spondylitis 15%
56. 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione 15%
57. Human Umbilical Vein Endothelial Cells 14%
58. Histones 14%
59. Messenger RNA 14%
60. Protein Isoforms 14%
61. quinoline 14%
62. Western Blotting 14%
63. Calcium 13%
64. Pharmaceutical Chemistry 13%
65. Antimitotic Agents 13%
66. 2,3,7,7a-tetrahydro-3-hydroxy-7-methyl-2-(prop-1-en-1-yl)-5H-furo(3,4-b)pyran-5-one 13%
67. A549 Cells 13%
68. MPT0B098 13%
69. MPT0L145 13%
70. Phosphotransferases 13%
71. Antibodies 13%
72. WMJ-S-001 13%
73. Pancreatic Neoplasms 13%
74. DNA Damage 13%
75. Lipopolysaccharides 13%
76. Cisplatin 12%
77. fosbretabulin 12%
78. Binding Sites 12%
79. Cohort Studies 12%
80. Polymerization 12%
81. HSP90 Heat-Shock Proteins 12%
82. Acute Myeloid Leukemia 12%
83. Benzamides 12%
84. Phosphatidylinositol 3-Kinases 12%
85. Anti-Inflammatory Agents 12%
86. Genetic Polymorphisms 12%
87. Transforming Growth Factors 12%
88. Caspase 3 12%
89. shikonin 12%
90. ErbB Receptors 12%
91. Osteoporosis 11%
92. Human Activities 11%
93. Colchicine 11%
94. Cell Survival 11%
95. Prostatic Neoplasms 11%
96. Matrix Metalloproteinase 9 11%
97. Coronary Vessels 11%
98. Computational Biology 11%
99. Inflammation 11%

Chemical Compounds

1. Histone 65%
2. Protein 49%
3. Antiproliferative 35%
4. Drug 34%
5. Antineoplastic Agent 30%
6. Hydroxamic Acid 24%
7. Antitumor 22%
8. Genetic Polymorphism 22%
9. Reactive Oxygen Metabolite 19%
10. Apoptotic 17%
11. Resistance 14%
12. Cell Death 14%
13. Osthole 14%
14. Temozolomide 14%
15. 50 Percent Growth Inhibition 14%
16. Colchicine 14%
17. Retinal 13%
18. Metabolite 13%
19. Polymerization Reaction 13%
20. Hispidulin 12%
21. Acetylation 12%
22. Bioavailability 11%
23. Genotoxicity 11%
24. Pharmacokinetics 10%
25. Antioxidant Agent 10%
26. Nanocarrier 10%
27. Disorder 9%
28. Growth Inhibition 9%
29. Vascular Targeting Agent 9%
30. Dose 9%
31. Cell Viability 9%
32. Glycol 9%
33. Binding Site 9%
34. Structure-Activity Relationship 9%
35. Western Blotting 9%
36. Calcium(0) 9%
37. Phosphotransferase Inhibitor 9%
38. Pharmacological Metabolism 8%
39. Shikonin 8%
40. Bioactivity 8%
41. Oxidative Stress 8%
42. Modification 8%
43. Retinal Pigment 8%
44. Protective 8%
45. Lipopolysaccharide 8%
46. Molecule 8%
47. Membrane Potential 8%
48. Flavonoid 8%
49. Vorinostat 7%
50. Marker 7%
51. Hydrocarbon 7%
52. Antigen 7%
53. Metabolic 7%
54. Biological Marker 7%
55. Cleavage 7%
56. Total Synthesis 7%
57. Occurrence in Nature 7%
58. Application 7%
59. Anilide 7%
60. Flow 7%
61. Weight 6%
62. Chemistry 6%
63. Chidamide 6%
64. Cantharidin 6%
65. Superoxide 6%
66. Alkannin 6%
67. Nanoparticle 6%
68. Heat 6%
69. Antiinflammatory 6%
70. Tyrosine 6%
71. Antimitotic Agent 6%
72. Poly(ethylene Glycol) 5%
73. Glucose 5%
74. Drug Target 5%
75. Lipid 5%
76. Indoline 5%
77. Substitution Reaction 5%
78. Plasma 5%
79. EC 2.7.12.2 (Mitogen-Activated Protein Kinase Kinase) Inhibitor 5%
80. Proliferative 5%
81. Genotoxic 5%
82. Antimitotic 5%
83. Chemoattractant 5%
84. Microtubule-Destabilising Agent 5%
85. Haematological 5%
86. Benzamide 5%
87. Clearance 5%
88. Enzyme Activity 5%
89. Antivascular 5%
90. Messenger RNA 5%
91. Aporphine 5%